CannTrust’s cannabis sales licence suspended by Health Canada

CannTrust Holdings Inc.’s licences to produce and sell recreational and medical cannabis in Canada were suspended by federal regulators on Tuesday, the latest blow to the beleaguered pot firm after an inspection uncovered that it grew thousands of kilograms of marijuana in unlicensed rooms.

CannTrust said in a statement that it received notice from Health Canada earlier Tuesday morning that it won’t be able to sell and produce cannabis, other than cultivating and harvesting existing plants.

“While the suspension remains in effect, CannTrust will be permitted to cultivate and harvest existing lots or batches previously propagated, as well as conducting ancillary activities to those lots, including drying, trimming and milling. During the suspension, CannTrust may not propagate new lots or batches of cannabis or engage in the sale or distribution of cannabis,” the company said in a statement.

CannTrust added the notice from Health Canada states the regulator could reinstate its licences “if the reasons for the suspension no longer exist or if CannTrust demonstrates that the suspension was unfounded.” The Vaughan, Ont.-based company said its management and board are reviewing the notice with its counsel and other advisors.

CannTrust said federal regulators listed several measures that the firm could implement, which would address the various public health and safety risks that contributed to Health Canada’s partial suspension.

Those measures include controlling the cannabis that comes in and out of the company’s facilities, ensuring that marijuana will be produced and distributed in authorized areas, recovering pot that was grown in unauthorized areas, improving employees’ knowledge and compliance with the law, and developing better record-keeping and inventory tracking.

In a separate statement sent to BNN Bloomberg, CannTrust said the company’s remediation efforts are underway and “significant progress has been made” in its operations to comply with Health Canada’s regulations.

“CannTrust’s paramount and urgent priority is to satisfy regulators that the company meets or exceeds all regulatory requirements so that the reasons for suspension no longer exist, we are in a position to resume operations and to regain the trust and confidence of our shareholders, patients, customers and partners,” said Robert Marcovitch, the company’s interim CEO, in an emailed statement.

CannTrust has been in a state of turmoil since July 8 when it revealed it had breached Canadian regulations by growing marijuana in unlicensed areas of its Pelham, Ont.-based facility.

As a result of that infraction, Health Canada seized nearly 5,200 kilograms of dried cannabis and the company instituted a voluntary hold on approximately 7,500 kg at another facility.

The pot firm has also fired CEO Peter Aceto with cause, demanded the resignation of chairman Eric Paul and formed a special committee tasked with probing the regulatory scandal. CannTrust also hired Greenhill & Co. as a financial advisor to explore a sale of the company, strategic investment or a business combination.

In August, CannTrust said Health Canada found that its Vaughan manufacturing facility was non-compliant as well. CannTrust also disclosed last month that the Ontario Securities Commission’s Joint Serious Offences Team had opened an investigation into “matters and parties” related to the company.

Earlier this month, BNN Bloomberg reported that some CannTrust staff late last year brought cannabis seeds from the black market into production rooms, leading to some illicitly-grown pot flowing into the legal market. 

CannTrust now joins a handful of Canadian cannabis producers which have had their ability to grow and sell legal cannabis suspended by Health Canada, the federal regulator in charge of enforcing and licensing pot in the country.

Last week, British Columbia-based Evergreen Medicinal Supply Inc.’s licence was suspended due to issues relating to its production practices, record-keeping, inventory control, and adherence to licence controls. In February, Bonify Holdings Corp.’s licences were suspended after the company was found to be selling marijuana it obtained from illicit sources.

2 cannabis stocks to watch before the end of the week

The marijuana stock market has shifted very rapidly over the course of the past few years. With so many pot stocks to watch and pot stocks to choose from, it seems as though the choice can be quite difficult. This choice, however, is just the reason you’re here. One of the key things to note about pot stocks is that they come from all around the industry. Companies in the cannabis stock market can be ancillary businesses such as marketing and packaging companies. Additionally, they can also be the raw growers of the substance itself.

All of these varying businesses have different reasons that make them pot stocks to watch. One of the key things to note is that these companies do usually come with a higher level of volatility than most. This is simply due to the fact that the pot stock market is still very much one of infancy. Volatility, however, can be positive for some investors as it allows for larger gains. One should keep in mind that it also can account for larger losses. All in all, these marijuana stocks to watch are working to shift the future of the industry for the better.

A Scientific Approach to Cannabis

Stilcanna Inc. (STIL Stock Report) (SCNNF Stock Report) is one of the leading CBD based businesses currently working out of the European extraction market. The company has stated that its proprietary technology allows them to have a larger scale CBD operation at a lower cost than most other competitors in the pot stock market. Within Europe, they have already signed into an exclusive contract for Dragonfly Biosciences LLC, a UK based CBD supplier. The company has stated that they also are working on the acquisition of other businesses in the pot stock market. With this, they should be able to grow their influence within the marijuana stock market overall and more specifically in Europe.

The company recently put out an operational update regarding their extraction facility based in Romania. With this new venture, they should be able to double the capacity of their current extraction equipment, where they then can fine-tune it to be fully up for industrial-scale production. When the machines are up and running, they will hopefully be able to produce any mixture of CBD-related compounds that a customer could order. For this reason among others, they remain a key pot stock to watch moving forward.

An Ancillary Pot Stock to Consider

KushCo Holdings (KSHB Stock Report) is one of the leading ancillary pot stocks in the market. The company has gone from a packaging solutions business to one with many facets spanning the whole pot stock market. The company currently operates in several different aspects of the cannabis stock market.

This includes extraction technology, infused edibles, packaging and branding solutions and more. Because they have such a broad scope, it seems as though they remain an interesting pot stock to watch. The company has made sure that they are working toward shifting the future of the pot stock market overall as it inevitably continues to change.

 

Cannabis tourism in Thailand – high time for medical marijuana-inspired travel

Thailand’s relationship with weed is one of highs and lows. The drug has long been used in traditional Thai medicine and cooking, but the possession, sale and use of cannabis was criminalised in 1934. However, that didn’t stop American troops who were stationed, or enjoying rest and recreation, in Thailand during the Vietnam war from developing a taste for the country’s infamous, indigenous strain – “dense, seedless, stronger than a bull elephant”, as per pot publication High Times. Those GIs helped its appeal to spread internationally; the word “bong” is said to have emerged from the Thai “baung”, which means a cylindrical wooden tube, via Vietnam veterans.

By the 1980s, Thailand had become one of the leading exporters of the plant, much to the chagrin of the United States, which eventually convinced the Southeast Asian nation to join its campaign against cannabis, effectively ending the illegal trade between the two countries (but turning Thai drug users onto methamphetamines; 177,847 people sought treatment for meth use in 2017, compared with 14,616 for marijuana, according to the United Nations Office on Drugs and Crime).

In 2016, then justice minister Paiboon Koomchaya declared the war on drugs lost and attitudes shifted, leading to the legalisation of marijuana for medical use last December, a landmark development that “could see the country return to its green glory days”, according to Vice magazine, and might influence drug policy across the region. “Thai cannabis will soon be the global industry’s profit leader, like Swiss watches or Apple smartphones,” Jim Plamondon, vice-president of marketing at the Chiang Mai-based Thai Cannabis Corporation, told Vice.

Thailand’s new tourism and sports minister, Pipat Ratchakitprakan, has high hopes for the economic benefits of weed tourism, too. “We would like to provide medical tour packages, such as detox, Thai massage and other wellness courses that use marijuana substances,” he said on his first day in office, in July, according to a Bangkok Post report. Yuthasak Supasorn, governor of the Tourism Authority of Thailand, seconded the minister, telling the newspaper that the agency was keen to promote medical marijuana to build “quality tourism”, meaning high-spending visitors from Europe and America, especially as arrivals from the country’s main source market, China, have fallen amid the Sino-US trade war.

 
 
A marijuana seedling at the first indoor cannabis farm in Thailand, in Pathum Thani province. Photo: EPA
A marijuana seedling at the first indoor cannabis farm in Thailand, in Pathum Thani province.

Cannabis tourism is on the rise around the world. In American states such as Colorado and California, companies lead tours of dispensaries and growing facilities, and even organise weed-fuelled art jams and cannabis cooking classes. And the billion-dollar industry is expanding as destinations from Barcelona to Lisbon relax regulations.

Cannabis research firm Prohibition Partners estimates that Thailand’s cannabis industry could grow to 21 billion baht (US$687 million) by 2024. “A regulated legal cannabis market could be transformative for patients, farmers and economies across Asia,” Daragh Anglim, managing director at Prohibition Partners, told the Bangkok Post in May. “From a financial standpoint, as the world’s most populous region, the legalisation of cannabis could encourage robust economic growth across the region, buoyed by both local and international demand.”

As Southeast Asia’s most progressive pot pioneer, when it comes to cashing in on cannabis tourism, even if it is confined to the medical marijuana market for the time being, Thailand is well positioned to take the lead. Or should that be, “toke the lead”?

 
 
As one of India’s most popular attractions, the Taj Mahal is no stranger to overtourism, welcoming up to 70,000 visitors a day at weekends and on public holidays. However, rather than limit the Unesco World Heritage Site’s opening hours, officials for tourism in Agra, the city in which the Taj is located, told CNN Travel on September 12 that they would be extending them. Currently accessible from sunrise to sunset every day except Friday, the Taj Mahal will be open to visitors who wish to see the marble marvel bathed in a lunar glow on five nights each month, immediately before, during and after the full moon. To book full-moon visits, tourists must contact the Archaeological Survey of India Office at 22 Mall Road, Agra, tel: 91 562 222 7261.

Amid the Japan-South Korea trade dispute, airline tickets in free fall

Amid another escalating trade war, travellers can take advantage of cheap flights from Seoul to various Japanese destinations. Photo: Shutterstock
Amid another escalating trade war, travellers can take advantage of cheap flights from Seoul to various Japanese destinations. Photo: Shutterstock
Share:
The US-China trade war might be dominating international headlines, but an escalating dispute between historical foes Japan and South Korea could also have a significant international economic impact as it threatens to disrupt global electronics supply chains. However, while nationalist rhetoric builds and tensions fray in both countries, an early beneficiary of the feud is the humble traveller, for whom flights across the Sea of Japan have rarely been more affordable.

On September 8, the Nikkei Asian Review reported that one-way ticket prices from smaller Japanese cities to South Korea’s capital, Seoul, have fallen to as little as 1,000 yen (US$9.3). CNN followed up with an article on September 10 stating that to get from Seoul to Fukuoka costs just 10,000 won (US$8.5), although admittedly these prices do exclude taxes and fuel surcharges.

At the time of writing, Destinations Known found one-way flights from Seoul to Osaka from HK$272 (US$35), all-in. Flying from Osaka to Seoul is marginally more expensive, at HK$386.

Despite market bumps, start-up humps, hemp to be a 2020 cash crop in Florida

The Florida Department of Agriculture expects to receive 8,000 applications by December and issue 3,000 cultivation permits early next year when the state rolls out its new industrial hemp program.

Some officials estimate the crop could eventually spawn a $30 billion annual industry in the Sunshine State but, as the Senate Agriculture Committee learned Tuesday, the rosy prospectus comes with thorns.

While 37 states have authorized industrial hemp programs in the two years since the crop was legalized under the federal 2018 Farm Bill, all await approval and guidance from the U.S. Department of Agriculture (USDA).

Yet, according to HempBenchmarks.com, there are already more than 400,000 acres producing hemp in 34 states under the 2014 Farm Bill’s pilot program, outpacing processing capacity and market development. As a result, the new domestic commodity’s price has been falling since May.

Nevertheless, State Director of Cannabis Holly Bell told lawmakers, “homegrown” hemp will be a “several million dollar industry that will become hundreds of millions in the next two years.”

Bell said Colorado, Vermont, New York, Kentucky and Tennessee are among states that have given farmers the green light to grow hemp after submitting plans to the USDA months ago without any federal interference.

Florida will do as well in early 2020, Bell said, although she expects USDA guidance before year’s end.

“Everybody else is doing it,” she said. The USDA has “not intervened and stopped any state. By December, if everything goes well, our team is ready to issue permits.”

Bell, hired in February by Agriculture Commissioner Nikki Fried as the state’s first cannabis czar after helping Tennessee establish its hemp industry during two decades of developing marijuana industries, said Florida’s program will include a workforce component and an automated permit process.

Without the USDA’s approval of the state’s program, however, Agriculture Committee Chairman Sen. Ben Albritton, R-Bartow, a Central Florida farmer, said many farmers who may be interested in adding hemp to their crop mix, – like himself – will be hesitant to do so until the feds sign off.

Sen. Bill Montford, D-Tallahassee, said hemp could be help the Panhandle recover from 2018’s Hurricane Michael.

In a February hearing before the Senate Agriculture Committee on Senate Bill 1020 – the 2019 bill lawmakers approved to create the state’s hemp program – University of Florida North Florida Research & Education Center Director Glen Aiken recommended hemp and hops as alternative crops for Panhandle farmers recovering from October’s Category 5 storm.

Aiken said there is increasing demand for hemp, which can be used for high-quality fibers and ropes, clothing, even as food.

“I know of an entrepreneur in Kentucky that processes hemp sausage,” he said. “It’s hemp and pork combined. I had some. It’s not the best sausage I’ve ever ate, but it wasn’t too bad either.”

During Tuesday’s pre-session committee primer, agricultural scientists from the University of Florida and FAMU gave presentations of hemp’s prospects in the Sunshine State.

UF Director Dr. Robert Gilbert feared growers could “get ahead of the science” on hemp and said there will be an “emerging crops” summit sometime soon.

Creating a state industrial hemp program has been a priority for Fried since she assumed office in January after being the only Democrat elected to a statewide office in November.

“It’s going to cause an industrial revolution in our state and across the country,” she said in support of SB 1020, noting hemp has as many as 35,000 different uses and its market as a cash crop is only getting brighter as it is considered as a biodegradable replacement for Styrofoam, plastic and paper.

SB 1020, sponsored by Sen. Rob Bradley, R-Fleming Island, was adopted by the House in a 112-1 vote and by the Senate in a 39-0 tally.